<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0">

<channel>
  <title>
      AMEinfo.com | Al Hikma Pharmaceuticals
    
  </title>
  <link>http://www.ameinfo.com/rssfeeds/9815.xml</link>
  <description>Al Hikma Pharmaceuticals news and features</description>
  <language>en-us</language>
  <copyright>(c) 1996-2013 AME Info FZ LLC / 4C. All rights reserved.</copyright>
  <lastBuildDate>Sat, 25 May 2013 00:18:55 +0400</lastBuildDate>
  <ttl>60</ttl>
  <image>
    <title>AMEinfo.com | </title>
    <width>125</width>
    <height>48</height>
    <link>http://www.ameinfo.com/rssfeeds/9815.xml</link>
    <url>http://www.ameinfo.comhttp://static.amefiles.com/static/r21/images/rss/logo_for_rss.jpg</url>
  </image>

  <item>
    <title>Hikma Pharmaceuticals a Regional Associate at World Economic Forum 2013</title>
    <link>http://www.ameinfo.com/hikma-pharmaceuticals-regional-associate-world-economic-341829</link>
    <guid isPermaLink="true">http://www.ameinfo.com/hikma-pharmaceuticals-regional-associate-world-economic-341829</guid>
    <pubDate>Thu, 16 May 2013 14:12:08 +0400</pubDate>
    <description>
      <![CDATA[
        Hikma Pharmaceuticals, the region's leading pharmaceutical manufacturer, announced that it will be partnering with the World Economic Forum 2013 as a Regional Associate as part of its on-going efforts to develop the economy and health sector in the Middle East and North Africa region.
        <br /><a href="http://oas6.ameinfo.com/RealMedia/ads/adstream_lx.ads/ameinfo.com/rss/159/x90/AME/AME-Info_RSS_Generic/AME-Info_RSS_Generic_px/125"><img src="http://oas6.ameinfo.com/RealMedia/ads/adstream_lx.ads/ameinfo.com/rss/159/x90/AME/AME-Info_RSS_Generic/AME-Info_RSS_Generic_px/125" width="1" height="1" /></a>
      ]]>
    </description>
    <enclosure url="http://static.amefiles.com/static/r21/images/news/9/1613939-medium_Final.jpg" type="image/jpeg" length="1500" />
  </item>
  <item>
    <title>Hikma signs licensing and marketing agreement for Dance Biopharm's inhaled insulin in MENA</title>
    <link>http://www.ameinfo.com/hikma-signs-licensing-marketing-agreement-dance-338711</link>
    <guid isPermaLink="true">http://www.ameinfo.com/hikma-signs-licensing-marketing-agreement-dance-338711</guid>
    <pubDate>Tue, 23 Apr 2013 10:38:42 +0400</pubDate>
    <description>
      <![CDATA[
        Hikma Pharmaceuticals PLC 'Hikma' announces the signing of a licensing and distribution agreement with Dance Biopharm for its proprietary inhaled insulin product, Dance 01, for the Middle East and Africa.  
      ]]>
    </description>
    <enclosure url="http://static.amefiles.com/static/r21/images/news/5/1596875-medium_hikmalogo.jpg" type="image/jpeg" length="1500" />
  </item>
  <item>
    <title>Hikma signs agreement with Sinclair IS Pharma to license Flammacerium for MENA region</title>
    <link>http://www.ameinfo.com/hikma-signs-agreement-sinclair-pharma-license-333835</link>
    <guid isPermaLink="true">http://www.ameinfo.com/hikma-signs-agreement-sinclair-pharma-license-333835</guid>
    <pubDate>Mon, 18 Mar 2013 13:39:01 +0400</pubDate>
    <description>
      <![CDATA[
        Hikma Pharmaceuticals today announces the signing of an exclusive ten-year collaboration and licensing agreement with Sinclair IS Pharma for Flammacerium, its leading hospital product for the prevention and treatment of infections from severe burn wounds, in the Middle East and North Africa (MENA) region.
      ]]>
    </description>
    <enclosure url="http://static.amefiles.com/static/r21/images/news/6/1570016-medium_hikmalogo.jpg" type="image/jpeg" length="1500" />
  </item>
  <item>
    <title>Hikma Pharmaceuticals invites top organizations to 'Towards a Smoke-Free Environment' session</title>
    <link>http://www.ameinfo.com/hikma-pharmaceuticals-invites-top-organizations-towards-330855</link>
    <guid isPermaLink="true">http://www.ameinfo.com/hikma-pharmaceuticals-invites-top-organizations-towards-330855</guid>
    <pubDate>Sun, 24 Feb 2013 11:26:29 +0400</pubDate>
    <description>
      <![CDATA[
        Setting an example for the MENA and the world on how corporations can become smoke-free, Jordan’s leading pharmaceutical manufacturer and Global Smoke-free Partnership (GSP) member, Hikma Pharmaceuticals, in collaboration with the Cancer Control Office (CCO) of King Hussein Cancer Center (KHCC) and the GSP, organized 'Towards a Smoke-Free Environment' session. 
      ]]>
    </description>
    <enclosure url="http://static.amefiles.com/static/r21/images/news/2/1553702-medium_hikma.jpg" type="image/jpeg" length="1500" />
  </item>
  <item>
    <title>Hikma signs licensing and distribution agreement with EffRx for its innovative osteoporosis medication</title>
    <link>http://www.ameinfo.com/hikma-signs-licensing-distribution-agreement-effrx-328206</link>
    <guid isPermaLink="true">http://www.ameinfo.com/hikma-signs-licensing-distribution-agreement-effrx-328206</guid>
    <pubDate>Sun, 03 Feb 2013 15:55:06 +0400</pubDate>
    <description>
      <![CDATA[
        Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) announces the signing of a licensing and distribution agreement with EffRx Pharmaceuticals SA for Binosto, its innovative osteoporosis medication, for the Middle East and North Africa region. Binosto is the first and only buffered solution for the treatment of osteoporosis, delivering fracture-risk reduction and offering the potential to improve adherence to therapy.  
      ]]>
    </description>
    <enclosure url="http://static.amefiles.com/static/r21/images/news/0/1539400-medium_hikma.jpg" type="image/jpeg" length="1500" />
  </item>

</channel>
</rss>
